Global Market Study on Gastrointestinal Stromal Tumor

Dec 2017| PMR577A| Persistence Market Research

Report Highlights

Persistence Market Research has developed an exclusive and in-depth market analysis and forecast for gastrointestinal stromal tumor (GIST). The report covers the expansion of gastrointestinal stromal tumor market across global, regional and local perimeters. The study has been developed to deliver accurate forecast on market size estimations for the assessment period, 2017-2026. From drug development and epidemiology analysis to market entry barriers and changing regulations in the healthcare industry – a range of causative factors for the growth of the global gastrointestinal stromal tumor market have been studied and applied. The impact of these factors is assessed to create presumptive scenarios on how the global gastrointestinal stromal tumor market will expand in the near future.

Companies partaking in the global gastrointestinal stromal tumor market can avail this report to understand the underlying premise of developments in GIST treatments and devise strategies based on the inferences provided in the report. This report serves as a reliable business document for pharmaceutical companies interested in extending their presence in the global gastrointestinal stromal tumor market in the upcoming years.

Report Synopsis

Analysis and forecast on the global gastrointestinal stromal tumor market has been provided in terms of market size estimations. The report includes a slew of sections reveal the estimated forecast on market and its key segments. The report provides an overview of the overall healthcare industry, addressing the latest trends and breakthrough happenings, which puts forth a connection between the changing healthcare landscape and the evolving marketplace for treatments on gastrointestinal stromal tumors.

Cost structure breakdown, pricing analysis, technology trends, FDA pipeline snapshot, and analysis on drug distribution network has been provided in the report as well. The report further delivers a detailed analysis on the competition landscape in the global gastrointestinal stromal tumor market. Current market standings of emerging players and leading companies are disclosed in this section. This report also reveals the strategic developments of market participants to give insights on competitive business growth towards future market direction.

Market Taxonomy

The report has segmented the global gastrointestinal stromal tumor market on the basis of regions, namely North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and Middle East and Africa. The report has provided country-specific forecast on the expansion of the overall gastrointestinal stromal tumor market. For extensive analysis, the global market for gastrointestinal stromal tumor is further segmented on the basis of indication, end-use and treatments.

On the basis of indication, the global gastrointestinal stromal tumor market is divided into:

Stomach
Small Intestine
Others
The key end-users in the global market for gastrointestinal stromal tumor include:

Hospitals
Clinics
Specialized Cancer Treatment Centers
Other End Users
Gastrointestinal stromal tumor treatments in the global market are:

Targeted Drug Therapy
Chemotherapy
Radiation Therapy
Surgery
Other Therapies
Research Methodology

A team of analysts, research associates, and subject matter experts has developed this report by tracing the key elements instrumenting the growth in the gastrointestinal stromal tumor market. The report has aggregates the revenues that the market participants have procured through GIST treatments over the recent past. This data has been employed to generate baseline for market size forecasting. Metrics such as Year-on-Year growth rate, absolute dollar opportunities, and compounded annual growth rates, have been used to interpret the forecasted data. The overall market size estimations provided in the report are in US dollars (US$). The scope of the report is to deliver accurate forecast on the future of global gastrointestinal stromal tumor market and enable market participants towards taking informed decisions and developing new strategies for business growth. Companies can avail this report to change their presence in the global GIST market and increase their stake in it.

  • Table 1 : Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2012-2017
  • Table 2 : Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2018-2026
  • Table 3 : Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • Table 4 : Global Stomach Segment Value (US$ Mn), By Region 2012-2017
  • Table 5 : Global Stomach Segment Value (US$ Mn), By Region 2018-2026
  • Table 6 : Global Stomach Segment Market Share, By Region 2012-2017
  • Table 7 : Global Stomach Segment Market Share, By Region 2018-2026
  • Table 8 : Global Stomach Segment Y-o-Y, By Region 2017-2026
  • Table 9 : Global Small Intestine Segment Value (US$ Mn), By Region 2012-2017
  • Table 10 : Global Small Intestine Segment Value (US$ Mn), By Region 2018-2026
  • Table 11 : Global Small Intestine Segment Market Share, By Region 2012-2017
  • Table 12 : Global Small Intestine Segment Market Share, By Region 2018-2026
  • Table 13 : Global Small Intestine Segment Y-o-Y, By Region 2017-2026
  • Table 14 : Global Others Segment Value (US$ Mn), By Region 2012-2017
  • Table 15 : Global Others Segment Value (US$ Mn), By Region 2018-2026
  • Table 16 : Global Others Segment Market Share, By Region 2012-2017
  • Table 17 : Global Others Segment Market Share, By Region 2018-2026
  • Table 18 : Global Others Segment Y-o-Y, By Region 2017-2026
  • Table 19 : Global Hospitals Segment Value (US$ Mn), By Region 2012-2017
  • Table 20 : Global Hospitals Segment Value (US$ Mn), By Region 2018-2026
  • Table 21 : Global Hospitals Segment Market Share, By Region 2012-2017
  • Table 22 : Global Hospitals Segment Market Share, By Region 2018-2026
  • Table 23 : Global Hospitals Segment Y-o-Y, By Region 2017-2026
  • Table 24 : Global Clinics Segment Value (US$ Mn), By Region 2012-2017
  • Table 25 : Global Clinics Segment Value (US$ Mn), By Region 2018-2026
  • Table 26 : Global Clinics Segment Market Share, By Region 2012-2017
  • Table 27 : Global Clinics Segment Market Share, By Region 2018-2026
  • Table 28 : Global Clinics Segment Y-o-Y, By Region 2017-2026
  • Table 29 : Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2012-2017
  • Table 30 : Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2018-2026
  • Table 31 : Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2012-2017
  • Table 32 : Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2018-2026
  • Table 33 : Global Specialized Cancer Treatment Centers Segment Y-o-Y, By Region 2017-2026
  • Table 34 : Global Other End Users Segment Value (US$ Mn), By Region 2012-2017
  • Table 35 : Global Other End Users Segment Value (US$ Mn), By Region 2018-2026
  • Table 36 : Global Other End Users Segment Market Share, By Region 2012-2017
  • Table 37 : Global Other End Users Segment Market Share, By Region 2018-2026
  • Table 38 : Global Other End Users Segment Y-o-Y, By Region 2017-2026
  • Table 39 : Global Targeted Drug Therapy Segment Value (US$ Mn), By Region 2012-2017
  • Table 40 : Global Targeted Drug Therapy Segment Value (US$ Mn), By Region 2018-2026
  • Table 41 : Global Targeted Drug Therapy Segment Market Share, By Region 2012-2017
  • Table 42 : Global Targeted Drug Therapy Segment Market Share, By Region 2018-2026
  • Table 43 : Global Targeted Drug Therapy Segment Y-o-Y, By Region 2017-2026
  • Table 44 : Global Chemotherapy Segment Value (US$ Mn), By Region 2012-2017
  • Table 45 : Global Chemotherapy Segment Value (US$ Mn), By Region 2018-2026
  • Table 46 : Global Chemotherapy Segment Market Share, By Region 2012-2017
  • Table 47 : Global Chemotherapy Segment Market Share, By Region 2018-2026
  • Table 48 : Global Chemotherapy Segment Y-o-Y, By Region 2017-2026
  • Table 49 : Global Radiation Therapy Segment Value (US$ Mn), By Region 2012-2017
  • Table 50 : Global Radiation Therapy Segment Value (US$ Mn), By Region 2018-2026
  • Table 51 : Global Radiation Therapy Segment Market Share, By Region 2012-2017
  • Table 52 : Global Radiation Therapy Segment Market Share, By Region 2018-2026
  • Table 53 : Global Radiation Therapy Segment Y-o-Y, By Region 2017-2026
  • Table 54 : Global Surgery Segment Value (US$ Mn), By Region 2012-2017
  • Table 55 : Global Surgery Segment Value (US$ Mn), By Region 2018-2026
  • Table 56 : Global Surgery Segment Market Share, By Region 2012-2017
  • Table 57 : Global Surgery Segment Market Share, By Region 2018-2026
  • Table 58 : Global Surgery Segment Y-o-Y, By Region 2017-2026
  • Table 59 : Global Other Therapies Segment Value (US$ Mn), By Region 2012-2017
  • Table 60 : Global Other Therapies Segment Value (US$ Mn), By Region 2018-2026
  • Table 61 : Global Other Therapies Segment Market Share, By Region 2012-2017
  • Table 62 : Global Other Therapies Segment Market Share, By Region 2018-2026
  • Table 63 : Global Other Therapies Segment Y-o-Y, By Region 2017-2026
  • Table 64 : North America Current Expenditure on Health, (% of GDP), by Country, 2010 � 2016
  • Table 65 : North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 66 : North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 67 : North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 68 : North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 69 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Table 70 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Table 71 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Table 72 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Table 73 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • Table 74 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Table 75 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Table 76 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • Table 77 : Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 � 2016
  • Table 78 : Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 79 : Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 80 : Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 81 : Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 82 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Table 83 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Table 84 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Table 85 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Table 86 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • Table 87 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Table 88 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Table 89 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • Table 90 : Europe Current Expenditure on Health, (% of GDP), by Country, 2010 � 2016
  • Table 91 : Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 92 : Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 93 : Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 94 : Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 95 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Table 96 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Table 97 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Table 98 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Table 99 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • Table 100 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Table 101 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Table 102 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • Table 103 : Japan Current Expenditure on Health, (% of GDP), by Country, 2010 � 2016
  • Table 104 : Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 105 : Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 106 : Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 107 : Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 108 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Table 109 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Table 110 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Table 111 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Table 112 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • Table 113 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Table 114 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Table 115 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • Table 116 : APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 � 2016
  • Table 117 : APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 118 : APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 119 : APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 120 : APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 121 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Table 122 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Table 123 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Table 124 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Table 125 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • Table 126 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Table 127 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Table 128 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • Table 129 : MEA Current Expenditure on Health, (% of GDP), by Country, 2010 � 2016
  • Table 130 : MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 131 : MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 132 : MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 133 : MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 134 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Table 135 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Table 136 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Table 137 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Table 138 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • Table 139 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Table 140 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Table 141 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • Figure 1 : Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2012-2017
  • Figure 2 : Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) Forecast, 2018-2026
  • Figure 3 : Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • Figure 4 : Global Stomach Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 5 : Global Stomach Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 6 : Global Stomach Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 7 : Global Small Intestine Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 8 : Global Small Intestine Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 9 : Global Small Intestine Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 10 : Global Others Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 11 : Global Others Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 12 : Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 13 : Global Hospitals Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 14 : Global Hospitals Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 15 : Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 16 : Global Clinics Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 17 : Global Clinics Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 18 : Global Clinics Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 19 : Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 20 : Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 21 : Global Specialized Cancer Treatment Centers Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 22 : Global Other End Users Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 23 : Global Other End Users Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 24 : Global Other End Users Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 25 : Global Targeted Drug Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 26 : Global Targeted Drug Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 27 : Global Targeted Drug Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 28 : Global Chemotherapy Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 29 : Global Chemotherapy Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 30 : Global Chemotherapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 31 : Global Radiation Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 32 : Global Radiation Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 33 : Global Radiation Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 34 : Global Surgery Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 35 : Global Surgery Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 36 : Global Surgery Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 37 : Global Other Therapies Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 38 : Global Other Therapies Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 39 : Global Other Therapies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 40 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Figure 41 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Figure 42 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Figure 43 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Figure 44 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • Figure 45 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Figure 46 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Figure 47 : North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • Figure 48 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Figure 49 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Figure 50 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Figure 51 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Figure 52 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • Figure 53 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Figure 54 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Figure 55 : Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • Figure 56 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Figure 57 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Figure 58 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Figure 59 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Figure 60 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • Figure 61 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Figure 62 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Figure 63 : Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • Figure 64 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Figure 65 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Figure 66 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Figure 67 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Figure 68 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Figure 69 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Figure 70 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Figure 71 : Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • Figure 72 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Figure 73 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Figure 74 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Figure 75 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Figure 76 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • Figure 77 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Figure 78 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Figure 79 : APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
  • Figure 80 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
  • Figure 81 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
  • Figure 82 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
  • Figure 83 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
  • Figure 84 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
  • Figure 85 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
  • Figure 86 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
  • Figure 87 : MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report